Alhemo (Concizumab-mtci Injection)

Alhemo (concizumab-mtci) is a tissue factor pathway inhibitor (TFPI) antagonist used for routine prophylaxis to help prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with: hemophilia A (congenital factor VIII deficiency) with FVIII inhibitors and hemophilia B (congenital factor IX deficiency) with FIX inhibitors.

Recommended Dosage: The recommended dose of Alhemo is administered by subcutaneous injection into the abdomen or thigh, with daily rotation of injection sites. On Day 1, a loading dose of 1 mg/kg is recommended. Starting Day 2, administer a once-daily dose of 0.2 mg/kg until the maintenance dose is determined. After 4 weeks, measure concizumab-mtci plasma concentration using an ELISA test (FDA-authorized test unavailable). Adjust the dose based on results no later than 8 weeks:

• <200 ng/mL: Increase to 0.25 mg/kg daily.
• 200–4,000 ng/mL: Continue 0.2 mg/kg daily.
• >4,000 ng/mL: Decrease to 0.15 mg/kg daily.

• Treatment with Concizumab-mtci 60 mg/1.5 mL (40 mg/mL), 150 mg/1.5 mL (100 mg/mL), and 300 mg/3 mL (100 mg/mL) may increase the risk of thromboembolic events. Patients with a known history of blood clots should be monitored closely. Inform your doctor about any symptoms like swelling, pain, or sudden breathlessness.
• Hypersensitivity reactions, including rashes, itching, or severe allergic responses, can occur with Alhemo injection. Patients should seek immediate medical attention if they experience difficulty breathing, swelling, or severe skin reactions after administration.
• Therapy with Concizumab-mtci injection can elevate fibrin D-dimer and prothrombin fragment 1+2 levels. Regular monitoring of these laboratory values is recommended to ensure appropriate treatment and avoid complications related to coagulation disorders.
• This therapeutic drug should be used during pregnancy only if clearly required. Consult your healthcare provider to evaluate potential risks to the unborn baby and ensure safety during pregnancy.
• Avoid using Concizumab-mtci injection while breastfeeding unless absolutely necessary. Discuss potential risks and benefits with your doctor to determine the best course of action for you and your baby.

What documents are required to import ALHEMO to India?
ALHEMO (concizumab-mtci) for injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ALHEMO available in India?

ALHEMO (concizumab-mtci injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Alhemo in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

ALHEMO can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ALHEMO (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Alhemo 60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ALHEMO (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Alhemo®?

Concizumab-mtci is a Generic Name for the trade name drug Alhemo®.

What is the Manufacturer's Name of Alhemo®?

Alhemo® is manufactured by Novo Nordisk Inc.

Is Alhemo® approved by the FDA?

Yes, Alhemo® is approved by the FDA. Date of first approval: December 20, 2024.

What is the dosage and form of Alhemo® supplied?

Alhemo is supplied in Injection: 60 mg/1.5 mL (40 mg/mL), 150 mg/1.5 mL (100 mg/mL), and 300 mg/3 mL (100 mg/mL) in a single-patient-use prefilled pen for subcutaneous use.

What are the most common side effects of Alhemo® injection?

The most common side effects of Alhemo® are injection site reactions and urticaria.

How much does Alhemo® injection cost in India?

Prices of Alhemo 60 mg/1.5 mL (40 mg/mL), 150 mg/1.5 mL (100 mg/mL), and 300 mg/3 mL (100 mg/mL) may fluctuate over time because of market dynamics and regulatory changes. To get the most recent details on Alhemo injection cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Alhemo® injection be available in SAARC countries?

Apart from Gulf countries, Alhemo® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Alhemo® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Alhemo® injections online in India?

Yes, one can buy Alhemo online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the legal supply of Alhemo® injections through legal channels.

What are the storage conditions of Alhemo® injections?

Store the vials of Alhemo in a refrigerator at 2°C–8°C. Protect from light, do not freeze, and keep out of reach of children.